Preclinical Activity of the B7-H3-Targeting Antibody-Drug Conjugate Vobramitamab Duocarmazine in Pediatric Solid Tumors. - Favours E; Tang H; Wong P; Ghilu S; Del Pozo V; Mironova E; Chen Y; Stearns T; Neuhauser S; Earley EJ; Erickson SW; Kwon JY; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2026)